Announce Date | 05/01/2024 |
EPS Normalized Actual | $2.88 (Beat by $0.09) |
EPS GAAP Actual | $2.88 (Beat by $0.09) |
Revenue Actual | $4.395B |
Revenue Surprise | Beat by $4395M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jun 2027 | 11.1542 | 22.62 | 10.94823 | 11.32161 | 4 |
Jun 2026 | 10.91297 | 23.12 | 10.78 | 11.15486 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 2.22 | 2.22 | 4.395B | 6.67% | 4395M |
FQ4 2021 (Dec 2021) | 1.65 | 1.65 | 3.9194B | 5.71% | 3919.4M |
FQ3 2021 (Sep 2021) | 1.66 | 1.66 | 3.7312B | 6.98% | 3731.2M |
FQ2 2021 (Jun 2021) | 1.27 | 1.27 | 3.737B | 9.64% | 3737M |
FQ1 2021 (Mar 2021) | 1.9 | 1.9 | 4.102B | 1.32% | 4102M |
FQ4 2020 (Dec 2020) | 1.51 | 1.51 | 3.6957B | 0.71% | 3695.7M |
FQ3 2020 (Sep 2020) | 1.4 | 1.4 | 3.4707B | -0.72% | 3470.7M |
FQ2 2020 (Jun 2020) | 0.96 | 0.96 | 3.3768B | -3.61% | 3376.8M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Jul 2026) | 2.56296 | -- | 2.53198 | 2.58666 | 3 |
FQ1 2026 (Mar 2026) | 3.27415 | -- | 3.23701 | 3.3034 | 9 |
FQ4 2025 (Oct 2025) | 2.44696 | -- | 2.41738 | 2.46959 | 4 |
FQ3 2025 (Jul 2025) | 2.31408 | -- | 2.2861 | 2.33548 | 4 |
FQ1 2025 (Mar 2025) | 3.01061 | -- | 2.97646 | 3.03751 | 6 |
FQ4 2024 (Oct 2024) | 2.25946 | -- | 2.21893 | 2.31012 | 9 |
FQ3 2024 (Jul 2024) | 2.07478 | -- | 2.01606 | 2.12371 | 12 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Jul 2026) | 5.32B | -- | 5.27B | 5.36B | 5 |
FQ1 2026 (Mar 2026) | 5.85B | -- | 5.8B | 5.89B | 5 |
FQ4 2025 (Oct 2025) | 5.06B | -- | 5.01B | 5.09B | 2 |
FQ3 2025 (Jul 2025) | 5.03B | -- | 4.98B | 5.06B | 2 |
FQ1 2025 (Mar 2025) | 5.53B | -- | 5.48B | 5.56B | 4 |
FQ4 2024 (Oct 2024) | 4.78B | -- | 4.74B | 4.8B | 7 |
FQ3 2024 (Jul 2024) | 4.75B | -- | 4.74B | 4.77B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 2.22 | 2.22 | 100% | |
FQ4 2021 (Dec 2021) | 1.65 | 1.65 | 100% | |
FQ3 2021 (Sep 2021) | 1.66 | 1.66 | 100% | |
FQ2 2021 (Jun 2021) | 1.27 | 1.27 | 100% | |
FQ1 2021 (Mar 2021) | 1.9 | 1.9 | 100% | |
FQ4 2020 (Dec 2020) | 1.51 | 1.51 | 100% | |
FQ3 2020 (Sep 2020) | 1.4 | 1.4 | 100% | |
FQ2 2020 (Jun 2020) | 0.96 | 0.96 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $4.4B | $4395M | 100% |
FQ4 2021 (Dec 2021) | $0B | $3.92B | $3919.4M | 100% |
FQ3 2021 (Sep 2021) | $0B | $3.73B | $3731.2M | 100% |
FQ2 2021 (Jun 2021) | $0B | $3.74B | $3737M | 100% |
FQ1 2021 (Mar 2021) | $0B | $4.1B | $4102M | 100% |
FQ4 2020 (Dec 2020) | $0B | $3.7B | $3695.7M | 100% |
FQ3 2020 (Sep 2020) | $0B | $3.47B | $3470.7M | 100% |
FQ2 2020 (Jun 2020) | $0B | $3.38B | $3376.8M | 100% |